Urologic Diseases Research Updates
Spring 2010
NIDDK Director Rodgers Elected
to Institute of Medicine
Griffin P. Rodgers, M.D., M.A.C.P., director of the
National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), has been elected to the
Institute of Medicine (IOM). Election to the IOM, one of the
highest honors in the fields of health and medicine, recognizes
individuals who have demonstrated outstanding professional achievement and
commitment to service.
“It is a great pleasure to welcome these distinguished
and accomplished individuals to the
Institute of Medicine,” said IOM President
Harvey V. Fineberg, Ph.D., M.D. “Each of these
new members stands out as a professional whose
research, knowledge, and skills have significantly
advanced health and medicine and who has
served as a model for others.”
Established in 1970 by the National Academy
of Sciences, the IOM is recognized as a national
resource for independent, scientifically informed
analyses and recommendations on health issues.
With their election, members make a commitment
to volunteer their services on IOM committees
and boards and participate in other IOM
activities.
Dr. Rodgers was named NIDDK director on
April 1, 2007. He had served as the NIDDK’s
acting director since March 2006 and was
the deputy director from 2001 to 2009. Dr.
Rodgers also has been chief of the Molecular
and Clinical Hematology Branch since 1998;
the branch is now administratively managed
by the National Institutes of Health’s National
Heart, Lung, and Blood Institute. As a research
investigator, Dr. Rodgers is widely recognized
for his contributions to the development of the
first effective—and now U.S. Food and Drug
Administration-approved—therapy for sickle
cell anemia.
NIH Publication No. 10–5743
April 2010
[Top] [Next Article]
|
